Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ; Collaborative Antiviral Study Group.
Mertz GJ, et al. Among authors: hjelle b.
Clin Infect Dis. 2004 Nov 1;39(9):1307-13. doi: 10.1086/425007. Epub 2004 Oct 11.
Clin Infect Dis. 2004.
PMID: 15494907
Clinical Trial.